Domestic violence happens 145 times every hour in the U.S. It affects more women than breast cancer, lung cancer and ovarian cancer combined. As part of Domestic Violence Awareness Month in October, The Allstate Foundation has partnered with actress Rosario Dawson for the Purple Purse campaign to raise awareness of domestic abuse and the role finances play in helping survivors break free from violence. In its third year, The Allstate Foundation Purple Purse campaign has pledged to donate up to $350,000 to the YWCA for programs that help domestic violence survivors gain the financial knowledge and resources needed to live independently.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62951-allstate-foundation-rosario-dawson-fight-domestic-violence-purple-purse
More than 80,000 healthcare workers and their communities from across the country and around the world joined together in the Medline Pink Glove Dance for breast cancer online video competition. After a hard-fought dance battle, the online votes are in and Medline is pleased to name Geisinger Health System, Danville, Pa., as the winner. As a result, $25,000 will be donated to their charity of choice, the American Cancer Society, providing free transportation for treatment to central Pennsylvania breast cancer patients in need. Additionally, Medline and participating hospitals will donate another $1 million to the National Breast Cancer Foundation and various local breast cancer charities nationwide. More than $2.2 million has been donated through the campaign and Medline Foundation since 2005.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64450-medline-pink-glove-dance-video-competition-winners-breast-cancer-education
Dune Medical Devices, Inc., announced today that its breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, the MarginProbe System, has received Premarket Approval (PMA) by the United States Food and Drug Administration. The technology significantly improves surgeons’ ability to intra-operatively identify
Phenogen Sciences, Inc. [www.phenogensciences.com] today announced the immediate availability of BREVAGen™, a predictive risk test for the millions of women at above average risk of developing estrogen-receptor positive breast cancer. This first-in-class, scientifically-validated risk assessment test examines a woman’s clinical risk factors, such as her lifetime exposure to estrogen, combined with scientifically validated genetic markers to determine each patient’s personalized five-year and lifetime risk of developing breast cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58399-phenogen-sciences-brevagen-breast-cancer-risk-assessment-test-availability
Pixee Fox, who has undergone many plastic surgeries from eye color implant to breast implant, butt lifting, and 6 ribs removal, travelled to Istanbul last week to be one step closer to her dream of becoming a cartoon character. Pixee shared the results of her Spider Web non surgical Face Lifting procedure, which was developed by Aesthetic Surgeon Bülent Cihantimur M.D.
Dr. Bülent Cihantimur, who listened to and examined Pixee Fox at his Istabul Byomed clinic prior to application, said: “Pixee was in need of a solution for her round face. She said she did not like her U shaped face and was looking for a V shaped contour line. Upon a friend’s recommendation, she went on my website and researched about Spider Web Face Lifting. After making contact, she came to Istanbul to undergo the Spider Web Face Lifting.”
Cihantimur contıunes: “The Spider Web Technique is a non-surgical procedure that shrinks, rejuvenates, and forms the face. In this technique I developed, fine needles are used to net medical threads that can dissolve just like a spider’s web under the skin. The body reacts to these threads and nets its own biological net around them. It boosts collagen production and increases lowered elastin.”
In recognition of Metastatic Breast Cancer Awareness Day on October 13, AstraZeneca (NYSE: AZN) is raising awareness about the thousands of U.S. women living with metastatic breast cancer. Metastatic Breast Cancer Awareness Day seeks to generate attention and greater support for women living with metastatic breast cancer among the public and stakeholders within the breast cancer community and more research to extend lives.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58129-mbc-awareness
Friends since 1988, Sheryl Crow and Melissa Etheridge have endured their share of hardships—bad breakups, depression and for Etheridge, the anxiety around coming out sexually. But they fought their toughest battle when, within two years of each other, Crow and Etheridge each received a breast cancer diagnosis, shaking their worlds to the core. Through sheer determination and perseverance, they came out the other side. Now healthy and happy, the two survivors sat down with AARP The Magazine to discuss what they've learned and how they've each found a renewed sense of self.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7334451-aarp-the-magazine-music-legends-sheryl-crow-and-melissa-etheridge-talk-about-beating-cancer/
Hologic, Inc. (NASDAQ: HOLX) is kicking off Breast Cancer Awareness Month with the announcement that the Company's groundbreaking 3D mammography exam, available on the Selenia Dimensions platform, will be introduced to consumers today as Genius 3D Mammography. Hologic’s Genius 3D Mammography is the only 3D exam approved by the FDA as clinically superior to traditional mammography.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7254155-hologic-new-consumer-awareness-campaign-mammography-technology/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
While Thanksgiving represents a time of tradition and family, it can also spell S-T-R-E-S-S for those planning a big feast. From figuring out how long to cook the turkey to putting together the perfect table setting, getting it all right can be really hard! To help you celebrate and prepare for your Thanksgiving feast, entertaining expert and cookbook author, Brooke Parkhurst has some great ideas and tips for a trouble-free turkey day. That way, when guests arrive - everyone will be able to relax, gobble, and enjoy!
Some of Brooke’s tips include:
• THANKS-GRIA- A delicious glass or two of wine is welcomed at any holiday gathering! Even easier? Put it in a pitcher so everyone can serve themselves. Lightly chill red wine and add a few spices and seasonal fruit to make a soon-to-be favorite holiday libation-- Thanks-gria!
• FORGET ABOUT FLOWERS, BUT DON’T FORGET YOUR HOSTS- Unless you have your own garden, decorating with fresh flowers can cost more than your meal. Instead, create centerpieces from seasonal fruits and vegetables, fresh greenery and berries. After the party’s over, make a meal from your centerpiece! And don’t forget about gift baskets for the hosts.
• JUICY WHITE MEAT- Who needs to roast the whole turkey when you can just bake the best part? The turkey breasts and legs cook at very different rates, which means that one will not be properly cooked. Instead, focus on cooking the turkey breast perfectly, roasting it at just the right temperature and saving a lot of time in the process.
• FRESH & FAST- It’s chilly out which makes us gravitate towards creamy, cheesy, heavy dishes. Want a little balance? Make your favorite potato casserole but off-set it with a delicious & easy arugula-pomegranate salad or butternut squash and ricotta crostini. Fresh dishes are usually the fastest to prepare!
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
